ANGLE plc (LON:AGL – Get Free Report)’s share price crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 2.35 and traded as low as GBX 2.33. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares.
ANGLE Price Performance
The company has a fifty day moving average of GBX 2.35 and a two-hundred day moving average of GBX 2.35. The company has a debt-to-equity ratio of 25.25, a quick ratio of 6.17 and a current ratio of 2.76. The company has a market cap of £7.58 million, a PE ratio of -0.49 and a beta of 0.22.
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
See Also
- Five stocks we like better than ANGLE
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
